We are live on ! Find out more
PAHC icon

Phibro Animal Health

136 hedge funds and large institutions have $242M invested in Phibro Animal Health in 2023 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 59 increasing their positions, 36 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 12

64% more repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 36

9% more funds holding

Funds holding: 125136 (+11)

4.08% more ownership

Funds ownership: 98.61%102.69% (+4.1%)

6% less capital invested

Capital invested by funds: $257M → $242M (-$15.2M)

57% less call options, than puts

Call options by funds: $27K | Put options by funds: $63K

Holders
136
Holders Change
+11
Holders Change %
+8.8%
% of All Funds
1.98%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
24
Increased
59
Reduced
36
Closed
12
Calls
$27K
Puts
$63K
Net Calls
-$36K
Net Calls Change
-$30K
Name Holding Trade Value Shares
Change
Change in
Stake
Wells Fargo
26
Wells Fargo
California
$1.31M -$1.03M -91,221 -45%
LSV Asset Management
27
LSV Asset Management
Illinois
$1.25M -$77.9K -6,900 -6%
State Board of Administration of Florida Retirement System
28
State Board of Administration of Florida Retirement System
Florida
$1.23M +$490K +43,421 +69%
Principal Financial Group
29
Principal Financial Group
Iowa
$1.23M -$44.7K -3,958 -4%
JP Morgan Chase
30
JP Morgan Chase
New York
$1.17M +$176K +15,603 +18%
Two Sigma Advisers
31
Two Sigma Advisers
New York
$1.12M +$419K +37,100 +62%
HF
32
HRT Financial
New York
$1.07M +$1.04M +92,222 New
Two Sigma Investments
33
Two Sigma Investments
New York
$1.04M +$824K +73,036 +428%
MAM
34
Martingale Asset Management
Massachusetts
$987K -$22.6K -2,003 -2%
RhumbLine Advisers
35
RhumbLine Advisers
Massachusetts
$962K +$66.5K +5,895 +8%
GCP
36
GSA Capital Partners
United Kingdom
$944K -$959 -85 -0.1%
FP
37
Factorial Partners
New York
$882K -$147K -13,000 -15%
BNP Paribas Financial Markets
38
BNP Paribas Financial Markets
France
$849K +$615K +54,506 +290%
TI
39
Trexquant Investment
Connecticut
$817K +$391K +34,674 +97%
Arrowstreet Capital
40
Arrowstreet Capital
Massachusetts
$749K -$62.2K -5,509 -8%
UBS Group
41
UBS Group
Switzerland
$725K +$209K +18,501 +42%
Barclays
42
Barclays
United Kingdom
$716K +$295K +26,174 +73%
Squarepoint
43
Squarepoint
New York
$711K +$693K +61,420 New
American Century Companies
44
American Century Companies
Missouri
$708K +$690K +61,122 New
CS
45
Credit Suisse
Switzerland
$663K +$90.8K +8,043 +16%
First Trust Advisors
46
First Trust Advisors
Illinois
$647K +$15K +1,328 +2%
D.E. Shaw & Co
47
D.E. Shaw & Co
New York
$644K +$145K +12,892 +30%
Legal & General Group
48
Legal & General Group
United Kingdom
$593K +$15.4K +1,364 +3%
Jacobs Levy Equity Management
49
Jacobs Levy Equity Management
New Jersey
$592K +$577K +51,083 New
CM
50
CastleKnight Management
New York
$554K

PAHC Hedge Fund Activity: Q4 2023 in Review

136 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Phibro Animal Health (PAHC) for Q4 2023, worth a combined $242M — down 5.9% from $257M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new PAHC positions and 12 closed out — a net gain of 12 holders — while 59 added to existing stakes and 36 trimmed.

The largest buyer was Millennium Management, adding an estimated $5.53M. The largest seller was Heartland Advisors, exiting entirely with an estimated $9.94M sold.

  • 136 institutional investors held Phibro Animal Health (PAHC) as of Q4 2023, up from 125 in Q3 2023.
  • Funds reported $242M of Phibro Animal Health stock for Q4 2023, down 5.9% quarter-over-quarter.
  • 24 funds opened new Phibro Animal Health positions in Q4 2023 and 12 closed out, a net change of +12 holders.
  • The largest Phibro Animal Health buyer in Q4 2023 was Millennium Management, an estimated $5.53M added.
  • The largest Phibro Animal Health seller in Q4 2023 was Heartland Advisors, an estimated $9.94M sold.

Based on aggregated 13F filings for Q4 2023.